{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T21:23:45Z","timestamp":1783977825987,"version":"3.55.0"},"reference-count":161,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T00:00:00Z","timestamp":1623888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100007231","name":"Cancerforeningen i Stockholm","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006769","name":"Russian Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002261","name":"Russian Foundation for Basic Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Swedish Cancer Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/j.bbcan.2021.188584","type":"journal-article","created":{"date-parts":[[2021,6,19]],"date-time":"2021-06-19T10:52:24Z","timestamp":1624099944000},"page":"188584","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Long non-coding RNAs: A view to kill ovarian cancer"],"prefix":"10.1016","volume":"1876","author":[{"given":"Alexey V.","family":"Zamaraev","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pavel I.","family":"Volik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennady T.","family":"Sukhikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelina S.","family":"Kopeina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Zhivotovsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbcan.2021.188584_bb0005","series-title":"Source: Globocan 2020, Globocan 2020","first-page":"3","volume":"419","author":"WHO","year":"2020"},{"key":"10.1016\/j.bbcan.2021.188584_bb0010","first-page":"284","article-title":"Ovarian cancer statistics, 2018","volume":"68","author":"Torre","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.bbcan.2021.188584_bb0015","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.soncn.2019.02.001","article-title":"Ovarian Cancer: An integrated review","volume":"35","author":"Stewart","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"10.1016\/j.bbcan.2021.188584_bb0020","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cell.2018.01.011","article-title":"Functional classification and experimental dissection of Long noncoding RNAs","volume":"172","author":"Kopp","year":"2018","journal-title":"Cell."},{"key":"10.1016\/j.bbcan.2021.188584_bb0025","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/nature21374","article-title":"An atlas of human long non-coding RNAs with accurate 5\u2032 ends","volume":"543","author":"Hon","year":"2017","journal-title":"Nature."},{"key":"10.1016\/j.bbcan.2021.188584_bb0030","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/ng.3192","article-title":"The landscape of long noncoding RNAs in the human transcriptome","volume":"47","author":"Iyer","year":"2015","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbcan.2021.188584_bb0035","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00018-016-2174-5","article-title":"Mechanisms of long noncoding RNA function in development and disease","volume":"73","author":"Schmitz","year":"2016","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0040","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.gpb.2015.09.006","article-title":"Roles, functions, and mechanisms of long non-coding RNAs in cancer","volume":"14","author":"Fang","year":"2016","journal-title":"Genom. Proteom. Bioinforma."},{"key":"10.1016\/j.bbcan.2021.188584_bb0045","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.devcel.2012.12.012","article-title":"The tissue-specific lncRNA Fendrr is an essential regulator of heart and Body Wall development in the mouse","volume":"24","author":"Grote","year":"2013","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbcan.2021.188584_bb0050","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2019.00936","article-title":"Enhancer lncrnas influence chromatin interactions in different ways","volume":"10","author":"Hou","year":"2019","journal-title":"Front. Genet."},{"key":"10.1016\/j.bbcan.2021.188584_bb0055","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2020.622294","article-title":"LncRNA-encoded peptide: functions and predicting methods","volume":"10","author":"Xing","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0060","doi-asserted-by":"crossref","DOI":"10.1038\/s12276-018-0188-9","article-title":"The emerging role of lncrnas in inflammatory bowel disease","volume":"50","author":"Yarani","year":"2018","journal-title":"Exp. Mol. Med."},{"key":"10.1016\/j.bbcan.2021.188584_bb0065","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1016\/j.bbagrm.2014.08.012","article-title":"LncRNA: a link between RNA and cancer","volume":"1839","author":"Yang","year":"2014","journal-title":"Biochim. Biophys. Acta - Gene Regul. Mech."},{"key":"10.1016\/j.bbcan.2021.188584_bb0070","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell."},{"key":"10.1016\/j.bbcan.2021.188584_bb0075","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1038\/nrg1656","article-title":"Telomeres and human disease: ageing, cancer and beyond","volume":"6","author":"Blasco","year":"2005","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.bbcan.2021.188584_bb0080","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0092-8674(00)80108-7","article-title":"Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis","volume":"86","author":"Hanahan","year":"1996","journal-title":"Cell."},{"key":"10.1016\/j.bbcan.2021.188584_bb0085","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrm2858","article-title":"Genomic instability an evolving hallmark of cancer","volume":"11","author":"Negrini","year":"2010","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0090","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM198612253152606","article-title":"Tumors: wounds that do not heal","volume":"315","author":"Flier","year":"1986","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbcan.2021.188584_bb0095","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1189\/jlb.1107774","article-title":"Immune-mediated dormancy: an equilibrium with cancer","volume":"84","author":"Teng","year":"2008","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0100","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science (80-.)."},{"key":"10.1016\/j.bbcan.2021.188584_bb0105","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1001\/jama.1931.02720490062043","article-title":"The metabolism of tumours: investigations from the Kaiser Wilhelm institute for biology, Berlin-Dahlem","volume":"96","year":"1931","journal-title":"JAMA J. Am. Med. Assoc."},{"key":"10.1016\/j.bbcan.2021.188584_bb0110","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S0898-6568(01)00271-6","article-title":"The protein kinase B\/Akt signalling pathway in human malignancy","volume":"14","author":"Nicholson","year":"2002","journal-title":"Cell. Signal."},{"key":"10.1016\/j.bbcan.2021.188584_bb0115","doi-asserted-by":"crossref","first-page":"325","DOI":"10.12659\/MSM.894913","article-title":"HOTAIR promotes proliferation, migration, and invasion of Ovarian cancer SKOV3 cells through regulating PIK3R3","volume":"22","author":"Dong","year":"2016","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbcan.2021.188584_bb0120","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1159\/000493408","article-title":"LncRNA HOTAIR regulates CCND1 and CCND2 expression by sponging miR-206 in ovarian cancer","volume":"49","author":"Chang","year":"2018","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.bbcan.2021.188584_bb0125","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.3892\/ol.2016.4435","article-title":"Inhibition of the long non-coding rna malat1 suppresses tumorigenicity and induces apoptosis in the human ovarian cancer skov3 cell line","volume":"11","author":"Liu","year":"2016","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2021.188584_bb0130","first-page":"3176","article-title":"LncRNA MALAT1 promotes proliferation and metastasis in epithelial ovarian cancer via the PI3K-AKT pathway","volume":"21","author":"Jin","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0135","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3233\/CBM-182160","article-title":"Upregulation of lncRNA AB073614 functions as a predictor of epithelial ovarian cancer prognosis and promotes tumor growth in vitro and in vivo","volume":"24","author":"Zeng","year":"2019","journal-title":"Cancer Biomarkers."},{"key":"10.1016\/j.bbcan.2021.188584_bb0140","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-017-0709-5","article-title":"Role of the lncRNA ABHD11-AS1 in the tumorigenesis and progression of epithelial ovarian cancer through targeted regulation of RhoC","volume":"16","author":"Wu","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2021.188584_bb0145","first-page":"3581","article-title":"Regulation of cell growth and cyclin D1 expression by the constitutively active FRAP-p70(s6K) pathway in human pancreatic cancer cells","volume":"59","author":"Grewe","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0150","doi-asserted-by":"crossref","first-page":"S104","DOI":"10.1016\/j.jmig.2017.08.338","article-title":"ElncRNA1, a long noncoding RNA that is transcriptionally induced by oestrogen, promotes epithelial ovarian cancer cell proliferation","volume":"24","author":"Qiu","year":"2017","journal-title":"J. Minim. Invasive Gynecol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0155","doi-asserted-by":"crossref","first-page":"32478","DOI":"10.18632\/oncotarget.8744","article-title":"The long non-coding RNA ANRIL promotes proliferation and cell cycle progression and inhibits apoptosis and senescence in epithelial ovarian cancer","volume":"7","author":"Qiu","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbcan.2021.188584_bb0160","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tcb.2004.09.014","article-title":"Renewing the conspiracy theory debate: does Raf function alone to mediate Ras oncogenesis?","volume":"14","author":"Repasky","year":"2004","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0165","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1210\/rp.56.1.127","article-title":"Ras activation of the Raf kinase: tyrosine kinase recruitment of the MAP kinase cascade","volume":"56","author":"Avruch","year":"2001","journal-title":"Recent Prog. Horm. Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0170","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1093\/hmg\/ddu502","article-title":"LncRNA-HOST2 regulates cell biological behaviors in epithelial ovarian cancer through a mechanism involving microRNA let-7b","volume":"24","author":"Gao","year":"2015","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbcan.2021.188584_bb0175","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3892\/ol.2012.609","article-title":"Regulation of let-7 and its target oncogenes (review)","volume":"3","author":"Wang","year":"2012","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2021.188584_bb0180","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1329-2","article-title":"Long non-coding RNA GAS5 inhibits DDP-resistance and tumor progression of epithelial ovarian cancer via GAS5-E2F4-PARP1-MAPK axis","volume":"38","author":"Long","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0185","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s12253-017-0258-7","article-title":"Downregulation of lncRNA TUBA4B is associated with poor prognosis for epithelial ovarian cancer","volume":"24","author":"Zhu","year":"2018","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0190","first-page":"406","article-title":"LINC01127 promotes the development of ovarian tumors by regulating the cell cycle","volume":"11","author":"Jing","year":"2019","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0195","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/j.ygyno.2013.09.034","article-title":"The Wnt\/\u03b2-catenin pathway in ovarian cancer: a review","volume":"131","author":"Arend","year":"2013","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0200","doi-asserted-by":"crossref","first-page":"6845","DOI":"10.2147\/OTT.S167900","article-title":"The lncRNA TUG1 promotes epithelial ovarian cancer cell proliferation and invasion via the WNT\/\u03b2-catenin pathway","volume":"11","author":"Liu","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbcan.2021.188584_bb0205","first-page":"4440","article-title":"LncRNA EBIC promoted proliferation, metastasis and cisplatin resistance of ovarian cancer cells and predicted poor survival in ovarian cancer patients","volume":"22","author":"Xu","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0210","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.biopha.2017.11.096","article-title":"LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt\/\u03b2-catenin signaling pathway","volume":"96","author":"Zhang","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2021.188584_bb0215","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20170681","article-title":"Up-regulation of long non-coding RNA SNHG20 promotes ovarian cancer progression via Wnt\/\u03b2-catenin signaling","volume":"38","author":"He","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0220","first-page":"2148","article-title":"LncRNA PCAT-1 plays an oncogenic role in epithelial ovarian cancer by modulating cyclinD1\/CDK4 expression","volume":"12","author":"Ding","year":"2019","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0225","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.5114\/aoms.2018.75535","article-title":"LncRNA myocardial infarction-associated transcript promotes cell proliferation and inhibits cell apoptosis by targeting miR-330-5p in epithelial ovarian cancer cells","volume":"14","author":"Shao","year":"2018","journal-title":"Arch. Med. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0230","first-page":"516","article-title":"LncRNA TP73-AS1 predicts poor prognosis and promotes cell proliferation in ovarian cancer via cell cycle and apoptosis regulation","volume":"18","author":"Xiuyun","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0235","first-page":"992","article-title":"Increased expression of lncRNA HULC in human epithelial ovarian cancer and its biological functions","volume":"39","author":"Mi","year":"2018","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0240","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.biopha.2018.09.103","article-title":"Long non-coding RNA LINC00460 promotes epithelial ovarian cancer progression by regulating microRNA-338-3p","volume":"108","author":"Liu","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2021.188584_bb0245","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1111\/cas.13552","article-title":"Long non-coding RNA RP11-552M11.4 promotes cells proliferation, migration and invasion by targeting BRCA2 in ovarian cancer","volume":"109","author":"Huang","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0250","first-page":"5809","article-title":"Long non-coding RNA LNC01133 promotes the tumorigenesis of ovarian cancer by sponging miR-126","volume":"11","author":"Hou","year":"2018","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0255","article-title":"E2F1-regulated long non-coding RNA RAD51-AS1 promotes cell cycle progression, inhibits apoptosis and predicts poor prognosis in epithelial ovarian cancer","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0260","first-page":"10082","article-title":"Ectopic expressed long non-coding RNA H19 contributes to malignant cell behavior of ovarian cancer","volume":"8","author":"Zhu","year":"2015","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0265","first-page":"2345","article-title":"LncRNA SNHG12 accelerates the progression of ovarian cancer via absorbing miRNA-129 to upregulate SOX4","volume":"23","author":"Sun","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0270","article-title":"Long non-coding RNA GEHT1 promoted the proliferation of ovarian cancer cells via modulating the protein stability of HIF1\u03b1","volume":"39","author":"Liu","year":"2019","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0275","first-page":"3621","article-title":"Long non-coding RNA DANCR upregulates IGF2 expression and promotes ovarian cancer progression","volume":"23","author":"Gao","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0280","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.bbrc.2018.11.006","article-title":"LncRNA LINC00319 accelerates ovarian cancer progression through miR-423-5p\/NACC1 pathway","volume":"507","author":"Du","year":"2018","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2021.188584_bb0285","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.jgg.2018.03.001","article-title":"A novel lncRNA, Lnc-OC1, promotes ovarian cancer cell proliferation and migration by sponging miR-34a and miR-34c","volume":"45","author":"Tao","year":"2018","journal-title":"J. Genet. Genom."},{"key":"10.1016\/j.bbcan.2021.188584_bb0290","first-page":"322","article-title":"LncRNA colon cancer-associated transcript 1 (CCAT1) promotes proliferation and metastasis of ovarian cancer via miR-1290","volume":"22","author":"Lai","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0295","doi-asserted-by":"crossref","DOI":"10.1186\/s13000-016-0499-x","article-title":"The long non-coding RNA CCAT2 is up-regulated in ovarian cancer and associated with poor prognosis","volume":"11","author":"Huang","year":"2016","journal-title":"Diagn. Pathol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0300","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1002\/cam4.710","article-title":"HuR-regulated lncRNA NEAT1 stability in tumorigenesis and progression of ovarian cancer","volume":"5","author":"Chai","year":"2016","journal-title":"Cancer Med."},{"key":"10.1016\/j.bbcan.2021.188584_bb0305","first-page":"7200","article-title":"Long non-coding rna lsinct5 promotes ovarian cancer cell proliferation, migration and invasion by disrupting the cxcl12\/cxcr4 signalling axis","volume":"15","author":"Long","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2021.188584_bb0310","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.12659\/MSM.908456","article-title":"CTD-2020k17.1, a novel long non-coding RNA, promotes migration, invasion, and proliferation of serous ovarian cancer cells in vitro","volume":"24","author":"Zhu","year":"2018","journal-title":"Med. Sci. Monit."},{"key":"10.1016\/j.bbcan.2021.188584_bb0315","first-page":"4094","article-title":"LncRNA EWSAT1 promotes ovarian cancer progression through targeting miR-330-5p expression","volume":"9","author":"Fu","year":"2017","journal-title":"Am. J. Transl. Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0320","first-page":"314","article-title":"Highly expressed long non-coding RNA DUXAP10 promotes proliferation of ovarian cancer","volume":"22","author":"Zhang","year":"2018","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0325","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s00011-018-1186-z","article-title":"LncRNA MEG3 impacts proliferation, invasion, and migration of ovarian cancer cells through regulating PTEN","volume":"67","author":"Wang","year":"2018","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0330","doi-asserted-by":"crossref","DOI":"10.3802\/jgo.2018.29.e99","article-title":"Upregulation of long non-coding RNA XIST has anticancer effects on epithelial ovarian cancer cells through inverse downregulation of hsa-miR-214-3p","volume":"29","author":"Wang","year":"2018","journal-title":"J. Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0335","first-page":"9264","article-title":"Long non-coding RNA NNT-AS1 contributes to cell proliferation, metastasis and apoptosis in human ovarian cancer","volume":"15","author":"Huang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2021.188584_bb0340","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1010428317709129","article-title":"Decreased long non-coding RNA SPRY4-IT1 contributes to ovarian cancer cell metastasis partly via affecting epithelial\u2013 mesenchymal transition","volume":"39","author":"Yu","year":"2017","journal-title":"Tumor Biol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0345","first-page":"3169","article-title":"Long non-coding RNA CPS1-IT1 is a positive prognostic factor and inhibits epithelial ovarian cancer tumorigenesis","volume":"21","author":"Wang","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0350","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/j.ijbiomac.2018.09.179","article-title":"LncRNA ADAMTS9-AS2 regulates ovarian cancer progression by targeting miR-182-5p\/FOXF2 signaling pathway","volume":"120","author":"Wang","year":"2018","journal-title":"Int. J. Biol. Macromol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0355","first-page":"5173","article-title":"Long non-coding RNA CASC2 inhibits progression and predicts favorable prognosis in epithelial ovarian cancer","volume":"18","author":"Xue","year":"2018","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0360","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.2147\/OTT.S125185","article-title":"A new tumor suppressor lncRNA RP11-190D6.2 inhibits the proliferation, migration, and invasion of epithelial ovarian cancer cells","volume":"10","author":"Tong","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbcan.2021.188584_bb0365","doi-asserted-by":"crossref","DOI":"10.1200\/EDBK_174718","article-title":"Whence high-grade serous ovarian cancer","author":"Kohn","year":"2017","journal-title":"Am. Soc. Clin. Oncol. Educ. B."},{"key":"10.1016\/j.bbcan.2021.188584_bb0370","doi-asserted-by":"crossref","DOI":"10.1038\/nrc4019","article-title":"Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer","author":"Bowtell","year":"2015","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbcan.2021.188584_bb0375","doi-asserted-by":"crossref","DOI":"10.1038\/s41419-018-1148-y","article-title":"The cisplatin-induced lncRNA PANDAR dictates the chemoresistance of ovarian cancer via regulating SFRS2-mediated p53 phosphorylation","volume":"9","author":"Wang","year":"2018","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2021.188584_bb0380","article-title":"LncRNA TUG1 promotes cells proliferation and inhibits cells apoptosis through regulating AURKA in epithelial ovarian cancer cells","volume":"97","author":"Li","year":"2018","journal-title":"Med. (United States)."},{"key":"10.1016\/j.bbcan.2021.188584_bb0385","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17010041","article-title":"Alisertib induces cell cycle arrest, apoptosis, autophagy and suppresses EMT in HT29 and Caco-2 cells","volume":"17","author":"Ren","year":"2015","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0390","doi-asserted-by":"crossref","first-page":"432","DOI":"10.4149\/neo_2015_051","article-title":"Involvement of SRPK1 in cisplatin resistance related to long non-coding RNA UCA1 in human ovarian cancer cells","volume":"62","author":"Wang","year":"2015","journal-title":"Neoplasma."},{"key":"10.1016\/j.bbcan.2021.188584_bb0395","first-page":"191","article-title":"Expression of lncRNAUCA1 in ovarian cancer and its clinical significance","volume":"38","author":"Qiu","year":"2017","journal-title":"Eur. J. Gynaecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0400","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1515\/hsz-2017-0274","article-title":"The effect of lncRNA HOTAIR on chemoresistance of ovarian cancer through regulation of HOXA7","volume":"399","author":"Liu","year":"2018","journal-title":"Biol. Chem."},{"key":"10.1016\/j.bbcan.2021.188584_bb0405","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1080\/15592294.2019.1633867","article-title":"EZH2 upregulates the PI3K\/AKT pathway through IGF1R and MYC in clinically aggressive chronic lymphocytic leukaemia","volume":"14","author":"Kosalai","year":"2019","journal-title":"Epigenetics."},{"key":"10.1016\/j.bbcan.2021.188584_bb0410","doi-asserted-by":"crossref","first-page":"3241","DOI":"10.3892\/or.2016.5200","article-title":"Decreased expression of long non-coding RNA GAS5 promotes cell proliferation, migration and invasion, and indicates a poor prognosis in ovarian cancer","volume":"36","author":"Li","year":"2016","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0415","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-00263-7","article-title":"Systems analysis of apoptotic priming in ovarian cancer identifies vulnerabilities and predictors of drug response","author":"Zervantonakis","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2021.188584_bb0420","doi-asserted-by":"crossref","first-page":"4905","DOI":"10.2147\/OTT.S142446","article-title":"NEAT1 regulates cell proliferation and apoptosis of ovarian cancer by miR-34a-5p\/BCL2","volume":"10","author":"Ding","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbcan.2021.188584_bb0425","doi-asserted-by":"crossref","first-page":"25381","DOI":"10.18632\/oncotarget.4541","article-title":"A long noncoding RNA AB073614 promotes tumorigenesis and predicts poor prognosis in ovarian cancer","volume":"6","author":"Cheng","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbcan.2021.188584_bb0430","doi-asserted-by":"crossref","first-page":"309","DOI":"10.5582\/bst.2018.01052","article-title":"Long non-coding RNA Linc00312 modulates the sensitivity of ovarian cancer to cisplatin via the Bcl-2\/Caspase-3 signaling pathway","volume":"12","author":"Zhang","year":"2018","journal-title":"Biosci. Trends."},{"key":"10.1016\/j.bbcan.2021.188584_bb0435","doi-asserted-by":"crossref","DOI":"10.4238\/gmr16019411","article-title":"Long non-coding RNA ENST00000457645 reverses cisplatin resistance in CP70 ovarian cancer cells","volume":"16","author":"Yan","year":"2017","journal-title":"Genet. Mol. Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0440","first-page":"20565","article-title":"Overexpression of long non-coding RNA PVT1 in ovarian cancer cells promotes cisplatin resistance by regulating apoptotic pathways","volume":"8","author":"Liu","year":"2015","journal-title":"Int. J. Clin. Exp. Med."},{"key":"10.1016\/j.bbcan.2021.188584_bb0445","doi-asserted-by":"crossref","first-page":"10431","DOI":"10.2147\/OTT.S266389","article-title":"LncRNA GAS8-AS1 inhibits ovarian cancer progression through activating beclin1-mediated autophagy","volume":"13","author":"Fang","year":"2020","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbcan.2021.188584_bb0450","doi-asserted-by":"crossref","first-page":"31714","DOI":"10.18632\/oncotarget.15955","article-title":"Upregulation of the lncRNA Meg3 induces autophagy to inhibit tumorigenesis and progression of epithelial ovarian carcinoma by regulating activity of ATG3","volume":"8","author":"Xiu","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbcan.2021.188584_bb0455","article-title":"LncRNA GAS5 suppresses ovarian cancer by inducing inflammasome formation","volume":"38","author":"Li","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0460","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.canlet.2009.09.017","article-title":"Epithelial-mesenchymal transition in ovarian cancer","volume":"291","author":"Vergara","year":"2010","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2021.188584_bb0465","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1038\/nrm3758","article-title":"Molecular mechanisms of epithelial-mesenchymal transition","volume":"15","author":"Lamouille","year":"2014","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0470","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2147\/OTT.S124645","article-title":"Long noncoding RNA NBAT-1 suppresses tumorigenesis and predicts favorable prognosis in ovarian cancer","volume":"10","author":"Yan","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbcan.2021.188584_bb0475","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8267863","article-title":"Long noncoding RNA MIR4697HG promotes cell growth and metastasis in human ovarian cancer","volume":"2017","author":"Zhang","year":"2017","journal-title":"Anal. Cell. Pathol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0480","doi-asserted-by":"crossref","first-page":"14221","DOI":"10.18632\/oncotarget.13991","article-title":"Roles of GSK-3 and microRNAs on epithelial mesenchymal transition and cancer stem cells","volume":"8","author":"McCubrey","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbcan.2021.188584_bb0485","doi-asserted-by":"crossref","first-page":"367","DOI":"10.3233\/CBM-170710","article-title":"Upregulation of SNHG3 expression associated with poor prognosis and enhances malignant progression of ovarian cancer","volume":"22","author":"Hong","year":"2018","journal-title":"Cancer Biomarkers."},{"key":"10.1016\/j.bbcan.2021.188584_bb0490","first-page":"3369","article-title":"Long non-coding RNA CCAT2 promotes epithelial-mesenchymal transition involving Wnt\/\u03b2-catenin pathway in epithelial ovarian carcinoma cells","volume":"15","author":"Wang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.bbcan.2021.188584_bb0495","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4143\/crt.2016.263","article-title":"Long non-coding RNA HOXA11 antisense promotes cell proliferation and invasion and predicts patient prognosis in serous ovarian cancer","volume":"49","author":"Yim","year":"2017","journal-title":"Cancer Res. Treat."},{"key":"10.1016\/j.bbcan.2021.188584_bb0500","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20081924","article-title":"Long noncoding RNA and epithelial mesenchymal transition in cancer","volume":"20","author":"Gugnoni","year":"2019","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0505","doi-asserted-by":"crossref","first-page":"782","DOI":"10.4149\/neo_2020_190617N515","article-title":"Lncrna CDKN2B-AS1 promotes the progression of ovarian cancer by MiR-143-3p\/SMAD3 axis and predicts a poor prognosis","volume":"67","author":"Xu","year":"2020","journal-title":"Neoplasma."},{"key":"10.1016\/j.bbcan.2021.188584_bb0510","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1111\/cas.13647","article-title":"Long non-coding RNA NEAT1 promoted ovarian cancer cells\u2019 metastasis through regulation of miR-382-3p\/ROCK1 axial","volume":"109","author":"Liu","year":"2018","journal-title":"Cancer Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0515","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2147\/OTT.S149908","article-title":"Long noncoding RNA H19 promotes transforming growth factor-\u03b2-induced epithelial\u2013mesenchymal transition by acting as a competing endogenous RNA of miR-370-3p in ovarian cancer cells","volume":"11","author":"Li","year":"2018","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbcan.2021.188584_bb0520","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20180936","article-title":"LINK-A lncRNA promotes migration and invasion of ovarian carcinoma cells by activating TGF-\u03b2 pathway","volume":"38","author":"Ma","year":"2018","journal-title":"Biosci. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0525","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0844-7","article-title":"Systematic analyses reveal long non-coding RNA (PTAF)-mediated promotion of EMT and invasion-metastasis in serous ovarian cancer","volume":"17","author":"Liang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2021.188584_bb0530","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-018-0604-1","article-title":"The lncRNA CCAT1 upregulates TGF\u03b2R1 via sponging miR-490-3p to promote TGF\u03b21-induced EMT of ovarian cancer cells","volume":"18","author":"Mu","year":"2018","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2021.188584_bb0535","doi-asserted-by":"crossref","DOI":"10.1186\/s12943-018-0870-5","article-title":"LncRNA PTAR promotes EMT and invasion-metastasis in serous ovarian cancer by competitively binding miR-101-3p to regulate ZEB1 expression","volume":"17","author":"Liang","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.bbcan.2021.188584_bb0540","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejphar.2019.03.002","article-title":"LncRNA FAM83H-AS1 contributes to the radioresistance, proliferation, and metastasis in ovarian cancer through stabilizing HuR protein","volume":"852","author":"Dou","year":"2019","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0545","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.biopha.2017.01.011","article-title":"Long non-coding RNA SNHG20 predicts a poor prognosis for HCC and promotes cell invasion by regulating the epithelial-to-mesenchymal transition","volume":"89","author":"Liu","year":"2017","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2021.188584_bb0550","first-page":"2360","article-title":"Long non-coding RNA OR3A4 promotes metastasis of ovarian cancer via inhibiting KLF6","volume":"23","author":"Guo","year":"2019","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0555","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.7150\/jca.29057","article-title":"Long non-coding RNA NONHSAT076754 promotes invasion and metastasis in epithelial ovarian cancer","volume":"10","author":"Lin","year":"2019","journal-title":"J. Cancer"},{"key":"10.1016\/j.bbcan.2021.188584_bb0560","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.486","article-title":"The lncRNA HULC functions as an oncogene by targeting ATG7 and ITGB1 in epithelial ovarian carcinoma","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2021.188584_bb0565","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.yexmp.2016.09.008","article-title":"Long non-coding RNA TUG1 regulates ovarian cancer proliferation and metastasis via affecting epithelial-mesenchymal transition","volume":"101","author":"Kuang","year":"2016","journal-title":"Exp. Mol. Pathol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0570","first-page":"2182","article-title":"Long non-coding RNA SOX2OT promotes cell proliferation and motility in human ovarian cancer","volume":"15","author":"Han","year":"2018","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.bbcan.2021.188584_bb0575","first-page":"5618","article-title":"Overexpression of lncRNA MNX1-AS1 is associated with poor clinical outcome in epithelial ovarian cancer","volume":"21","author":"Li","year":"2017","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0580","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-017-01781-0","article-title":"Decoding critical long non-coding RNA in ovarian cancer epithelial-to-mesenchymal transition","volume":"8","author":"Mitra","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbcan.2021.188584_bb0585","first-page":"402","article-title":"Antisense lncRNA As-SLC7A11 suppresses epithelial ovarian cancer progression mainly by targeting SLC7A11","volume":"72","author":"Yuan","year":"2017","journal-title":"Pharmazie."},{"key":"10.1016\/j.bbcan.2021.188584_bb0590","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2017.421","article-title":"Long noncoding RNA XIST expedites metastasis and modulates epithelial-mesenchymal transition in colorectal cancer","volume":"8","author":"Chen","year":"2017","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.bbcan.2021.188584_bb0595","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.bbcan.2021.188584_bb0600","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/onc.2009.441","article-title":"Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics","volume":"29","author":"Semenza","year":"2010","journal-title":"Oncogene."},{"key":"10.1016\/j.bbcan.2021.188584_bb0605","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.ccr.2008.05.005","article-title":"Tumor cell metabolism: cancer\u2019s Achilles\u2019 heel","volume":"13","author":"Kroemer","year":"2008","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bbcan.2021.188584_bb0610","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1016\/j.celrep.2014.08.028","article-title":"HIF-1-mediated suppression of acyl-CoA dehydrogenases and fatty acid oxidation is critical for cancer progression","volume":"8","author":"Huang","year":"2014","journal-title":"Cell Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0615","first-page":"467","article-title":"LINC00662 promotes glycolysis and cell survival by regulating mir-375\/HIF-1\u03b1 axis in ovarian cancer","volume":"34","author":"Tao","year":"2020","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"10.1016\/j.bbcan.2021.188584_bb0620","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1158\/0008-5472.CAN-16-1615","article-title":"Long noncoding RNA LINC00092 acts in cancer-associated fibroblasts to drive glycolysis and progression of ovarian cancer","volume":"77","author":"Zhao","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0625","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ygyno.2018.06.013","article-title":"The lncRNA SNHG3 regulates energy metabolism of ovarian cancer by an analysis of mitochondrial proteomes","volume":"150","author":"Li","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0630","doi-asserted-by":"crossref","DOI":"10.1016\/j.lfs.2020.118636","article-title":"LncRNA HOXB-AS3 promotes growth, invasion and migration of epithelial ovarian cancer by altering glycolysis","volume":"264","author":"Xu","year":"2021","journal-title":"Life Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0635","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s11010-019-03647-z","article-title":"Long non-coding RNA LINC00504 regulates the Warburg effect in ovarian cancer through inhibition of miR-1244","volume":"464","author":"Liu","year":"2020","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.bbcan.2021.188584_bb0640","doi-asserted-by":"crossref","first-page":"17122","DOI":"10.18632\/aging.103653","article-title":"Long non-coding RNA SNHG12 promotes immune escape of ovarian cancer cells through their crosstalk with M2 macrophages","volume":"12","author":"Qian","year":"2020","journal-title":"Aging (Albany NY)"},{"key":"10.1016\/j.bbcan.2021.188584_bb0645","doi-asserted-by":"crossref","DOI":"10.1186\/s13046-019-1394-6","article-title":"Long non-coding RNA HOTTIP enhances IL-6 expression to potentiate immune escape of ovarian cancer cells by upregulating the expression of PD-L1 in neutrophils","volume":"38","author":"Shang","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0650","doi-asserted-by":"crossref","first-page":"2141","DOI":"10.2147\/CMAR.S229013","article-title":"LncRNA EMX2OS induces proliferation, invasion and sphere formation of ovarian cancer cells via regulating the miR-654-3p\/AKT3\/PD-L1 axis","volume":"12","author":"Duan","year":"2020","journal-title":"Cancer Manag. Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0655","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2020.12.036","article-title":"Long non-coding RNAs at work on telomeres: Functions and implications in cancer therapy","author":"Gala","year":"2021","journal-title":"Cancer Lett."},{"key":"10.1016\/j.bbcan.2021.188584_bb0660","doi-asserted-by":"crossref","DOI":"10.1006\/gyno.1999.5668","article-title":"2-5A antisense directed against telomerase RNA produces apoptosis in ovarian cancer cells","author":"Kushner","year":"2000","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0665","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1089\/dna.2019.4826","article-title":"Cox-LASSO analysis reveals a ten-lncRNA signature to predict outcomes in patients with high-grade serous ovarian cancer","volume":"38","author":"Xu","year":"2019","journal-title":"DNA Cell Biol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0670","doi-asserted-by":"crossref","first-page":"11656","DOI":"10.1111\/jcmm.15873","article-title":"Biological functions and clinical applications of exosomal long non-coding RNAs in cancer","volume":"24","author":"Wang","year":"2020","journal-title":"J. Cell. Mol. Med."},{"key":"10.1016\/j.bbcan.2021.188584_bb0675","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.7150\/ijbs.28048","article-title":"Exosomal metastasis-associated lung adenocarcinoma transcript 1 promotes angiogenesis and predicts poor prognosis in epithelial ovarian cancer","volume":"14","author":"Qiu","year":"2018","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.bbcan.2021.188584_bb0680","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.3892\/ijo.2015.2943","article-title":"Long non-coding RNA ANRIL predicts poor prognosis and promotes invasion\/metastasis in serous ovarian cancer","volume":"46","author":"Qiu","year":"2015","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0685","article-title":"Long non-coding RNA taurine-upregulated gene 1 predicts unfavorable prognosis, promotes cells proliferation, and inhibits cells apoptosis in epithelial ovarian cancer","volume":"97","author":"Li","year":"2018","journal-title":"Med. (United States)."},{"key":"10.1016\/j.bbcan.2021.188584_bb0690","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.ygyno.2018.08.032","article-title":"Lowly-expressed lncRNA GAS5 facilitates progression of ovarian cancer through targeting miR-196-5p and thereby regulating HOXA5","volume":"151","author":"Zhao","year":"2018","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0695","first-page":"2644","article-title":"MALAT1 affects ovarian cancer cell behavior and patient survival","volume":"39","author":"Lin","year":"2018","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0700","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.3934\/mbe.2020110","article-title":"Long non-coding RNA XIST is down-regulated and correlated to better prognosis in ovarian cancer","volume":"17","author":"Hu","year":"2020","journal-title":"Math. Biosci. Eng."},{"key":"10.1016\/j.bbcan.2021.188584_bb0705","doi-asserted-by":"crossref","first-page":"34745","DOI":"10.18632\/oncotarget.5784","article-title":"A functional variant in HOXA 11-AS, a novel long non-coding RNA, inhibits the oncogenic phenotype of epithelial ovarian cancer","volume":"6","author":"Richards","year":"2015","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbcan.2021.188584_bb0710","doi-asserted-by":"crossref","first-page":"41047","DOI":"10.18632\/oncotarget.8535","article-title":"Genetic variants of lncRNA HOTAIR and risk of epithelial ovarian cancer among Chinese women","volume":"7","author":"Wu","year":"2016","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbcan.2021.188584_bb0715","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109810","article-title":"Identification three LncRNA prognostic signature of ovarian cancer based on genome-wide copy number variation","volume":"124","author":"Zheng","year":"2020","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.bbcan.2021.188584_bb0720","doi-asserted-by":"crossref","first-page":"4640","DOI":"10.1016\/j.ygeno.2020.08.005","article-title":"Tissue-based long non-coding RNAs \u201cPVT1, TUG1 and MEG3\u201d signature predicts Cisplatin resistance in ovarian Cancer","volume":"112","author":"El-Khazragy","year":"2020","journal-title":"Genomics."},{"key":"10.1016\/j.bbcan.2021.188584_bb0725","doi-asserted-by":"crossref","DOI":"10.1016\/j.ygyno.2019.12.020","article-title":"The influence of long non-coding RNAs on the response to chemotherapy in ovarian cancer","author":"Wambecke","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0730","doi-asserted-by":"crossref","first-page":"5377","DOI":"10.2147\/OTT.S147586","article-title":"LncRNA NEATI contributes to paclitaxel resistance of ovarian cancer cells by regulating ZEBI expression via miR-194","volume":"10","author":"An","year":"2017","journal-title":"Onco. Targets. Ther."},{"key":"10.1016\/j.bbcan.2021.188584_bb0735","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.bbrc.2020.03.087","article-title":"LncRNA TLR8-AS1 promotes metastasis and chemoresistance of ovarian cancer through enhancing TLR8 mRNA stability","volume":"526","author":"Xu","year":"2020","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.bbcan.2021.188584_bb0740","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2019.01549","article-title":"Long non-coding RNAs involved in resistance to chemotherapy in ovarian cancer","volume":"9","author":"Abildgaard","year":"2020","journal-title":"Front. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0745","doi-asserted-by":"crossref","first-page":"66","DOI":"10.29245\/2572-9411\/2016\/3.1066","article-title":"Mini-review on current strategies to knockdown long non-coding RNAs","volume":"1","author":"Behlke","year":"2016","journal-title":"J. Rare Dis. Res. Treat."},{"key":"10.1016\/j.bbcan.2021.188584_bb0750","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1093\/nar\/30.9.1911","article-title":"Design of antisense oligonucleotides stabilized by locked nucleic acids","volume":"30","author":"Kurreck","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0755","doi-asserted-by":"crossref","first-page":"3185","DOI":"10.1093\/nar\/gkg409","article-title":"Comparison of different antisense strategies in mammalian cells using locked nucleic acids, 2\u2032-O-methyl RNA, phosphorothioates and small interfering RNA","volume":"31","author":"Gr\u00fcnweller","year":"2003","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0760","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.addr.2015.01.008","article-title":"Pharmacokinetics, biodistribution and cell uptake of antisense oligonucleotides","volume":"87","author":"Geary","year":"2015","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.bbcan.2021.188584_bb0765","doi-asserted-by":"crossref","DOI":"10.15252\/embr.201846955","article-title":"Modulating the expression of long non-coding RNA s for functional studies","volume":"19","author":"Liu","year":"2018","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbcan.2021.188584_bb0770","doi-asserted-by":"crossref","DOI":"10.1186\/s13045-019-0748-z","article-title":"Noncoding RNAs in cancer therapy resistance and targeted drug development","volume":"12","author":"Wang","year":"2019","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.bbcan.2021.188584_bb0775","doi-asserted-by":"crossref","first-page":"9634","DOI":"10.18632\/oncotarget.14176","article-title":"Inhibition of long non-coding RNA UCA1 by CRISPR\/Cas9 attenuated malignant phenotypes of bladder cancer","volume":"8","author":"Zhen","year":"2017","journal-title":"Oncotarget."},{"key":"10.1016\/j.bbcan.2021.188584_bb0780","doi-asserted-by":"crossref","first-page":"5624","DOI":"10.1074\/jbc.M116.769034","article-title":"Biallelic insertion of a transcriptional terminator via the CRISPR\/Cas9 system efficiently silences expression of protein-coding and non-coding RNA genes","volume":"292","author":"Liu","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.bbcan.2021.188584_bb0785","article-title":"Challenges of CRISPR\/Cas9 applications for long non-coding RNA genes","volume":"45","author":"Goyal","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0790","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-017-0430-x","article-title":"Suppression of endothelial cell migration by tumor associated macrophage-derived exosomes is reversed by epithelial ovarian cancer exosomal lncRNA","volume":"17","author":"Wu","year":"2017","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bbcan.2021.188584_bb0795","doi-asserted-by":"crossref","first-page":"S243","DOI":"10.21037\/tcr.2017.10.46","article-title":"Exosomal lncRNAs as new players in cell-to-cell communication","volume":"7","author":"Dragomir","year":"2018","journal-title":"Transl. Cancer Res."},{"key":"10.1016\/j.bbcan.2021.188584_bb0800","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00404-017-4293-0","article-title":"A phase 1\/2a, dose-escalation, safety, pharmacokinetic, and preliminary efficacy study of intraperitoneal administration of BC-819 (H19-DTA) in subjects with recurrent ovarian\/peritoneal cancer","volume":"295","author":"Lavie","year":"2017","journal-title":"Arch. Gynecol. Obstet."},{"key":"10.1016\/j.bbcan.2021.188584_bb0805","unstructured":"No Title, (n.d.). https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03719300."}],"container-title":["Biochimica et Biophysica Acta (BBA) - Reviews on Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X21000810?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304419X21000810?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,5]],"date-time":"2025-10-05T04:48:32Z","timestamp":1759639712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304419X21000810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8]]},"references-count":161,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S0304419X21000810"],"URL":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188584","relation":{},"ISSN":["0304-419X"],"issn-type":[{"value":"0304-419X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long non-coding RNAs: A view to kill ovarian cancer","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Reviews on Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbcan.2021.188584","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"188584"}}